Mawallafi: Janice Evans
Ranar Halitta: 27 Yuli 2021
Sabuntawa: 16 Nuwamba 2024
Anonim
Bifidobacterium breve Bif195 Protects Against Small-Intestinal Damage Caused by Acetylsalicylic...
Video: Bifidobacterium breve Bif195 Protects Against Small-Intestinal Damage Caused by Acetylsalicylic...

Wadatacce

Bifidobacteria rukuni ne na ƙwayoyin cuta waɗanda yawanci suke rayuwa a cikin hanji. Za a iya yin girma a waje da jiki sannan a ɗauka ta baki azaman magani.

Bifidobacteria ana yawan amfani dashi don gudawa, maƙarƙashiya, rashin lafiyar hanji da ake kira cututtukan hanji, don hana sanyi ko mura, da sauran yanayi, amma babu kyakkyawar shaidar kimiyya don tallafawa yawancin waɗannan amfani.

Ciwon kwayar cutar Coronavirus 2019 (COVID-19): Babu wata kyakkyawar shaida don tallafawa ta amfani da bifidobacteria don COVID-19. Bi zaɓin rayuwa mai kyau da ingantattun hanyoyin rigakafin maimakon.

Magunguna na Compwararren Bayanan Bayanai ƙimar tasiri bisa ga shaidar kimiyya bisa ga mizani mai zuwa: Inganci, Mai yuwuwa Mai Yiwuwa, Yiwuwar Tasiri, Yiwuwar Mara Inganci, Mai yiwuwa Mara Inganci, Mara Inganci, da suarancin Shaida don Rate.

Effectivenessimar tasiri don BIFIDOBACTERIA sune kamar haka:

Yiwuwar tasiri ga ...

  • Maƙarƙashiya. Mafi yawan bincike ya nuna cewa shan bifidobacteria na iya kara saurin motsawar hanji da kusan bawul 1.5 a mako a cikin mutanen da ke da maƙarƙashiya. Amma ba duk matsalolin bifidobacteria ke neman aiki ba.
  • Cututtuka na narkewa wanda zai haifar da ulcers (Helicobacter pylori ko H. pylori). Shan bifidobacteria da lactobacillus tare da daidaitaccen maganin H. pylori na iya taimakawa wajen kawar da cututtukan H. pylori kusan sau biyu tare da shan daidaitaccen maganin H. pylori shi kadai. Hakanan zai iya rage illa kamar gudawa da ɗanɗano mara kyau daga maganin H. pylori.
  • Rashin lafiya na dogon lokaci na manyan hanji wanda ke haifar da ciwon ciki (ciwon mara na hanji ko IBS). Mafi yawan bincike ya nuna cewa shan bifidobacteria na makwanni 4-8 na iya rage alamun IBS kamar ciwon ciki, kumburin ciki, da wahalar samun hanji. Hakanan yana iya rage alamun bayyanar cututtuka kamar damuwa da damuwa cikin mutane tare da IBS. Amma ba duk matsalolin bifidobacteria ke neman aiki ba.
  • Wani matsala bayan tiyata don ulcerative colitis (pouchitis). Shan hadewar bifidobacteria da lactobacillus, tare da ko ba tare da streptococcus ba, da alama bakin zai taimaka wajen hana pouchitis bayan tiyata don ulcerative colitis.
  • Kamuwa da hanyoyin iska. Yawancin bincike sun nuna cewa yin amfani da maganin rigakafi wanda ke ɗauke da bifidobacteria yana taimakawa hana kamuwa da cututtukan iska kamar sanyi a cikin wasu ƙoshin lafiya, in har da yara masu makaranta da ɗaliban kwaleji. Amma shan bifidobacteria da alama bai rage haɗarin kamuwa da cututtukan iska a cikin yara da ke asibiti da matasa ko kuma cikin tsofaffi da ke cikin kulawa.
  • Gudawa da cutar rotavirus ta haddasa. Baiwa jarirai masu cutar zazzabin rotaviral na iya rage tsawon lokacin gudawa da kimanin kwana ɗaya.
  • Gudawar matafiya. Shan bifidobacteria na taimakawa hana zawowar matafiya yayin amfani da wasu kwayoyin kariya kamar lactobacillus ko streptococcus.
  • Wani nau'in cututtukan hanji mai kumburi (ulcerative colitis). Bincike ya nuna cewa shan kwayoyi masu dauke da sinadarin bifidobacteria tare da lactobacillus da streptococcus na iya taimakawa wajen kara saurin yafiya da kusan kashi 2 cikin mutane masu fama da cutar ulcerative colitis. Koyaya, yawancin bincike yana nuna cewa bifidobacteria baya da amfani don hana sake komowa.

Zai yuwu bashi da tasiri ga ...

  • Rage ƙwaƙwalwar ajiya da ƙwarewar tunani waɗanda ke faruwa daidai da shekaru. Bifidobacteria ba ze inganta ƙwarewar tunani da ƙwarewar ƙwaƙwalwar ajiya a cikin tsofaffi tare da ƙaurawar al'ada ta ƙwarewar tunani.
  • Kamuwa da cututtukan ciki ta hanyar ƙwayoyin cuta da ake kira Clostridium wuya. Mafi yawan bincike ya nuna cewa shan bifidobacteria tare da wasu kwayoyin rigakafi baya hana gudawa da Clostridium ke fama da ita.
  • Ci gaban jarirai. Bada dabara mai dauke da bifidobacteria da lactobacillus baya inganta ci gaban jarirai.
  • Kiba. Yawancin bincike sun nuna cewa shan bifidobacteria na tsawon watanni 6 baya inganta asarar nauyi ga mutanen da suke da kiba ko masu kiba.
  • Ciwon jini (sepsis). Dingara bifidobacteria a cikin madarar jarirai baya hana sepsis ga jariran da basu isa haihuwa ba.

Evidencearancin shaida don kimanta inganci don ...

  • Gudawa a cikin mutanen da ke shan maganin rigakafi (cututtukan da ke hade da kwayoyin cuta). Bincike ya nuna cewa shan bifidobacteria tare da maganin rigakafi na iya rage damar gudawa da kimanin kashi 45%. Amma akwai wasu sakamako masu karo da juna. Yana yiwuwa bifidobacteria na iya hana zawo wanda wasu magungunan rigakafi ke haifarwa amma ba wasu ba. Hakanan, bifidobacteria na iya aiki mafi kyau yayin amfani da shi a cikin wasu haɗuwa tare da lactobacillus da streptococcus. Amma ba duk haɗuwa suke aiki ba.
  • Wasan motsa jiki. Binciken farko ya nuna cewa shan bifidobacteria yana taimaka wa 'yan wasan da aka horar su gudu sosai a cikin adadin lokaci.
  • Cancanta (atopic dermatitis). Wasu bincike sun nuna cewa bada bifidobacterium ga jarirai na iya taimakawa TREAT eczema, amma akwai sakamako masu karo da juna. Sauran binciken sun nuna cewa bayar da bifidobacteria da lactobacillus ga mata masu juna biyu a cikin watanni 2 na karshe na daukar ciki, sannan kuma a ba jariri na watanni 2 na farko bayan haihuwa, na iya taimaka RIGAR eczema. Amma akwai sakamako masu karo da juna. Bai wa jarirai masu haɗari tare da lactobacillus a cikin watanni shidan farko na rayuwa ba ya hana eczema.
  • Celiac cuta. Bincike na farko ya nuna cewa shan bifidobacteria a matsayin wani bangare na abinci marar yalwar abinci ba ya inganta ciwan ciki da na hanji idan aka kwatanta da abinci shi kaɗai a cikin yara masu fama da cutar celiac.
  • Rage ƙwaƙwalwar ajiya da ƙwarewar tunani a cikin tsofaffi waɗanda ya fi abin da ke al'ada ga shekarunsu. Wasu bincike sun nuna cewa shan bifidobacteria yana inganta ƙwaƙwalwar ajiya a cikin mutane masu raguwar ƙwarewar tunani, amma da alama ba zai taimaka da harshe ko ikon ba da hankali ba.
  • Haƙori. Binciken farko ya nuna cewa cin yogurt na 'ya'yan itace tare da bifidobacteria na tsawon makonni 2 baya rage alamun hakori a cikin yara.
  • Gudawa. Binciken farko da aka gudanar ya gano cewa kara bifidobacteria zuwa Saccharomyces boulardii na da nasaba da kara rage gudawa ga yara da saurin zawo.
  • Allerji ga itacen al'ul na ƙasar Japan. Wasu bincike sun nuna cewa shan bifidobacteria a lokacin fulanin na rage hanci da alamun ido na cutar itacen al'ul na kasar Japan. Amma akwai sakamako masu karo da juna. Bifidobacteria da alama ba zai rage atishawa ko alamun alamun makogwaro da ke da alaƙa da itacen al'ul na ƙasar Japan.
  • Cutar mai tsanani a cikin jarirai wanda bai isa haihuwa ba (necrotizing enterocolitis ko NEC). Bincike ya nuna cewa bayar da bifidobacteria ita kadai ga jarirai masu ciki ba zai hana wannan yanayin ba. Amma ba da bifidobacteria tare da lactobacillus na iya samun ɗan fa'ida.
  • Tsanani rashin lafiya sanadiyyar kamuwa da radiation. Binciken farko ya nuna cewa bifidobacteria mai jure kwayoyin cuta na iya taimakawa inganta rayuwa na gajeren lokaci kan maganin cututtukan radiation. A haɗe tare da maganin rigakafi, bifidobacteria ya bayyana don taimakawa hana ƙwayoyin cuta masu haɗari daga girma da haifar da kamuwa da cuta mai tsanani.
  • Rheumatoid amosanin gabbai (RA).
  • Cututtuka na koda, mafitsara, ko mafitsara (cututtukan urinary ko UTIs).
  • Tsufa.
  • Ciwon nono, mai yiwuwa saboda kamuwa da cuta (mastitis).
  • Ciwon daji.
  • Cutar rashin lafiya.
  • Cututtuka a cikin mutanen da aka kula da su tare da kwayoyi masu cutar kansa.
  • Ci gaban yara.
  • Girma da bunƙasa a cikin jarirai waɗanda ba a haifa ba.
  • Rage ko toshewar kwararar bile daga hanta (cholestasis).
  • Ciwon suga.
  • Rashin haƙuri na Lactose.
  • Matsalar hanta.
  • Cutar Lyme.
  • Pswazo.
  • Ciwon jijiyoyin jiki da motsa jiki ya haifar.
  • Babban matakan cholesterol ko sauran mai (lipids) a cikin jini (hyperlipidemia).
  • Kumburi (kumburi) da kuma kitse a cikin hanta a cikin mutanen da ke shan kaɗan ko kuma ba giya ba (nonalcohol steatohepatitis ko NASH).
  • Kumburi (kumburi) da sores a cikin bakin (mucositis na baki).
  • Cutar gudawa da aka samu ta hanyar maganin radiation.
  • Sauya kwayoyin amfani da aka cire ta gudawa.
  • Matsalolin ciki.
  • Turawa.
  • Sauran yanayi.
Ana buƙatar ƙarin shaida don kimanta bifidobacteria don waɗannan amfani.

Yawancin kwayoyin cuta da sauran kwayoyin halitta suna rayuwa cikin jikinmu koyaushe. Kwayoyin "Abokai" kamar su bifidobacteria na iya taimaka mana wajen ragargaza abinci, shan abubuwan gina jiki, da yaƙi da ƙwayoyin "mara daɗi" waɗanda zasu iya haifar da cututtuka irin su gudawa.

Lokacin shan ta bakin: Bifidobacteria ne LAFIYA LAFIYA ga lafiyayyun manya idan aka sha su da kyau. A wasu mutane, jiyya tare da bifidobacteria na iya dagula ciki da hanji, haifar da gudawa, kumburin ciki da gas.

Kariya & Gargaɗi na Musamman:

Ciki da shan nono: Wani takamaiman nau'in bifidobacteria, Bifidobacterium bifidum, shine MALAM LAFIYA lokacin da aka sha bakinka daidai da makonni 6 yayin daukar ciki. Babu wadataccen ingantaccen bayani game da amincin shan wasu matsalolin na bifidobacteria idan kuna ciki ko ciyar da nono. Kasance a gefen aminci ka guji amfani.

Yara: Bifidobacteria ne LAFIYA LAFIYA ga yara masu zafi lokacin da aka ɗauke ta bakin da ta dace. Kodayake akwai lokuta na kamuwa da cutar jini tare da bifidobacteria a cikin jarirai masu ciwo mai tsanani, waɗannan sharuɗɗan ba safai ba.

Karfin garkuwar jiki: Akwai wata damuwa cewa "maganin rigakafi" na iya girma sosai a cikin mutanen da ke da rauni da garkuwar jiki da haifar da cututtuka. Kodayake wannan bai faru ba musamman tare da bifidobacteria, akwai lokuta da yawa da suka shafi wasu nau'o'in ƙwayoyin cuta kamar Lactobacillus. Idan kuna da rauni game da garkuwar jiki (misali, kuna da HIV / AIDS ko kuna shan magani na kansar), bincika likitanku kafin amfani da bifidobacteria.

Toshewa a cikin hanji: An bayar da rahoto sau biyu na kamuwa da jini ga jarirai da aka ba kwayar rigakafin bifidobacteria. A lokuta biyun, an yiwa jarirai tiyatar ciki. Ana tunanin cewa cututtukan jini sun samo asali ne daga toshewar hanji sanadiyyar aikin tiyatar ciki, wanda ya ba da damar bifidobacteria ya haye cikin jini. A wani yanayi, shan bifidobacteria bayan an gyara toshewar hanji bai haifar da wata cutar ta jini ba. Saboda haka haɗarin kamuwa da jini ba damuwa ga yawancin jarirai masu shan bifidobacteria ba. Amma ya kamata a yi amfani da bifidobacteria cikin tsanaki ko kaucewa cikin jarirai masu ciwon ciki ko na hanji.

Matsakaici
Yi hankali da wannan haɗin.
Magungunan rigakafi
Ana amfani da maganin rigakafi don rage kwayoyin cuta masu illa a jiki. Magungunan rigakafi na iya rage ƙwayoyin cuta masu kyau a jiki. Bifidobacteria wani nau'in ƙwayoyin cuta ne masu ƙawance. Shan kwayoyin rigakafi tare da bifidobacteria na iya rage tasirin bifidobacteria. Don kauce wa wannan hulɗar, ɗauki kayan bifidobacteria aƙalla awanni biyu kafin ko bayan maganin rigakafi.
Babu sanannun hulɗa tare da ganye da kari.
Babu sanannun hulɗa da abinci.
An yi nazarin ƙwayoyi masu zuwa a cikin binciken kimiyya:

MAGABATA

DA BAKI:
  • Don maƙarƙashiya: An yi amfani da rukunin bifidobacteria miliyan 100 zuwa miliyan 20 na mulkin mallaka kowace rana. A mafi yawan lokuta, ana shan bifidobacteria a kowace rana don makonni 1-4. A wasu lokuta an dauki sassan da suka hada da biliyan 5-60 na bifidobacteria tare da lactobacillus kowace rana sati 1 zuwa wata 1.
  • Don cuta na dogon lokaci na manyan hanji wanda ke haifar da ciwon ciki (ciwon mara na hanji ko IBS): Don inganta cututtukan ciki da na hanji, ana amfani da rukunin bifidobacteria miliyan 100 zuwa biliyan biliyan kowace rana tsawon makonni 4-8. Hakanan, ana amfani da raka'a biliyan 5 na bifidobacteria da lactobacillus da streptococcus sau biyu a kowace rana tsawon sati 4. Don inganta ɓacin rai da damuwa a cikin mutanen da ke tare da IBS, ana amfani da rukunin biif na mulkin mallaka biliyan 10 sau ɗaya kowace rana don makonni 6.
  • Don kamuwa da hanyoyin iska: An yi amfani da raka'a biliyan biyu na mulkin mallaka na bifidobacteria kowace rana tsawon makonni 6.
  • Don rikitarwa bayan tiyata don ulcerative colitis (pouchitis): ana ba da kashi kimanin tiriliyan 3 na tsarin mulkin mallaka na bifodobacteria da lactobacillus da streptococcus sau ɗaya a rana har tsawon watanni 12.
  • Don cututtukan ƙwayar narkewa wanda zai haifar da ulcers (Helicobacter pylori ko H. pylori): Rukunan bifidobacteria biliyan 5 da suka hada da lactobacillus a kullum tsawon sati 1 yayin maganin H. pylori da kuma sati daya bayan haka.
  • Ga wani nau'in cututtukan hanji mai kumburi (ulcerative colitis): Don kara yawan gafara, ana amfani da gram 3 kwatankwacin biliyan biliyan 900 na lactobacillus da bifidobacteria da streptococcus sau ɗaya ko sau biyu a kowace rana.
YARA

DA BAKI:
  • Don maƙarƙashiya: Rukunin kafa bifidobacteria biliyan 1 da digo 1 da 100 na mulkin mallaka a kowacce rana tsawon makonni 4 anyi amfani dasu ga yara yan shekaru 3-16.
  • Rashin lafiya na dogon lokaci na manyan hanji wanda ke haifar da ciwon ciki (ciwon mara na hanji ko IBS): An yi amfani da raka'o'in kafa miliyoyin biliyan na bifidobacteria kowace rana tsawon makonni 4.
  • Don kamuwa da hanyoyin iska: An yi amfani da raka'a biyu da suka hada da bifidobacteria da lactobacillus sau biyu a kowace rana a cikin yara masu shekaru 3-13.
  • Ga gudawa da rotavirus ke haifarwa: Bifidobacteria, tare ko tare da streptococcus, an yi amfani dashi ga yara har zuwa shekaru 3. Hakanan, ana amfani da bifidobacteria da lactobacillus sau biyu a rana tsawon kwanaki 3.
  • Ga wani nau'in cututtukan hanji mai kumburi (ulcerative colitis): Har zuwa bifidobacteria har zuwa lactobacillus da streptococcus ana amfani dasu har zuwa tiriliyan 1.8 na mulkin mallaka kowace rana har zuwa shekara 1 a cikin yara masu shekaru 1-16.
B. Bifidum, B. Breve, B. Infantis, B. lactis, B. Longum, Bifido, Bifido Bacterium Longum, Bifidobacterias, Bifidobactérie, Bifidobactéries, Bifidobacterium, Bifidobacterium matasa; Bifidobacterium animalis, Bifidobacterium bifidum; Bifidobacterium breve; Bifidobacterium jarirai; Bifidobacterium lactis; Bifidobacterium longum, Bifidum, Bifidus, Bifidus Brevis, Bifidus Infantis, Bifidus Longum, Bifidobacteria Bifidus, Lactobacillus Bifidus, L. Bifidus, Probiotic, Probiotique.

Don ƙarin koyo game da yadda aka rubuta wannan labarin, da fatan za a duba Magunguna na Compwararren Bayanan Bayanai hanya.


  1. Athalye-Jape G, Minaee N, Nathan E, et al. Sakamako a cikin ƙaramin lokacin da ya dace da dacewa da jariran ciki bayan Bifidobacterium breve M-16 V supplementation. J Matern Fetal Neonatal Med. 2020; 33: 2209-2215. Duba m.
  2. Wu G, Chen X, Cui N, et al. Rigakafin sakamako na Bifidobacterium supplementation a kan neonatal cholestasis a cikin ƙananan yara waɗanda ba su da haihuwa tare da ƙarancin nauyin haihuwa. Ayyukan Gastroenterol Res. 2020; 2020: 4625315. Duba m.
  3. Xiao J, Katsumata N, Bernier F, et al. Probiotic bifidobacterium breve don inganta ayyukan haɓaka na tsofaffi tare da tsammanin rashin lahani na rashin hankali: Tsarin bazuwar, makafi biyu, gwajin sarrafa wuribo. J Alzheimers Dis. 2020; 77: 139-147. Duba m.
  4. Lin CL, Hsu YJ, Ho HH, da sauransu. Bifidobacterium longum ƙarami. longum OLP-01 kari yayin horo mai jurewa yana inganta aikin motsa jiki a tsakiyar da masu tsere mai nisa: Gwajin makafi mai ido biyu. Kayan abinci. 2020; 12: 1972. Duba m.
  5. Lewis ED, Antony JM, Crowley DC, et al. Inganci na Lactobacillus paracasei HA-196 da Bifidobacterium longum R0175 a cikin sauƙaƙe alamun cututtukan cututtukan hanji (IBS): Nazarin bazuwar, nazarin wuribo. Kayan abinci. 2020; 12: 1159. Duba m.
  6. Michael DR, Jack AA, Masetti G, et al. Nazarin da aka gudanar bazuwar ya nuna kari na manya da kiba tare da lactobacilli da bifidobacteria yana rage nauyin jiki da inganta lafiya. Sci Rep. 2020; 10: 4183. Duba m.
  7. Czajeczny D, Kabzi & nacute; ska K, Wójciak RW. Shin probiotic supplementation yana taimakawa asarar nauyi? Nazarin bazuwar, makaho guda, nazarin-wuribo tare da Bifidobacterium lactis BS01 da Lactobacillus acidophilus LA02 kari. Ci Rashin nauyi. 2020. Duba m.
  8. Jiao X, Fu MD, Wang YY, Xue J, Zhang Y. Bifidobacterium da Lactobacillus don hana ƙananan ƙwayoyin cuta a cikin ƙananan ƙananan ƙananan yara masu haihuwa: nazari na yau da kullun da meta-bincike. Duniya J Pediatr. 2020; 16: 135-142. Duba m.
  9. Sadeghi-Bojd S, Naghshizadian R, Mazaheri M, Ghane Sharbaf F, Assadi F. Inganci na probiotic prophylaxis bayan farkon kamuwa da cutar yoyon fitsari a yara tare da hanyoyin fitsari na al'ada. J Ciwon Yara na Yara Dis Soc. 2020; 9: 305-310. Duba m.
  10. Butler CC, Lau M, Gillespie D, et al. Hanyoyin amfani da rigakafi akan gudanar da maganin rigakafi tsakanin mazauna gida masu kulawa: Gwajin gwaji na asibiti. JAMA. 2020; 324: 47-56. Duba m.
  11. Zhu XL, Tang XG, Qu F, Zheng Y, Zhang WH, Diao YQ. Bifidobacterium na iya amfani da rigakafin cutar necrotizing enterocolitis a cikin jarirai masu ciki: Binciken da aka tsara da kuma nazarin meta. Int J Surg. 2019; 61: 17-25. Duba m.
  12. Wang G, Feng D. Sakamakon magani na Saccharomyces boulardii haɗe tare da Bifidobacterium kuma kan aikin rigakafin salula a cikin yara masu fama da zawo mai tsanani. Exp Ther na aikin likita. 2019; 18: 2653-2659. Duba m.
  13. Sharif A, Kashani HH, Nasri E, Soleimani Z, Sharif MR. Matsayi na Probiotics a cikin Jiyya na Dysentery: Gwajin Clinical Double-Blind Clinical. Probiotics Antimicrob Sunadaran. Magani. 2017; 9: 380-385. Duba m.
  14. Pruccoli G, Silvestro E, Pace Napoleone C, Aidala E, Garazzino S, Scolfaro C. Shin maganin rigakafin lafiya ne? Bifidobacterium bacteremia a cikin yaro mai tsananin raunin zuciya. Infez Likita. 2019; 27: 175-178. Duba m.
  15. Manzhalii E, Virchenko O, Falalyeyeva T, Beregova T, Stremmel W. Kula da inganci na shirye-shiryen rigakafi don marasa giya steatohepatitis: Gwajin gwaji. J Dig Dis. Magani. 2017; 18: 698-703. Duba m.
  16. Kobayashi Y, Kuhara T, Oki M, Xiao JZ. Hanyoyin Bifidobacterium breve A1 akan aikin hankali na tsofaffi tare da ƙararrakin ƙwaƙwalwar ajiya: bazuwar, makafi biyu, gwajin sarrafa wuribo. Fananan Microbes. 2019; 10: 511-520. Duba m.
  17. Jiang C, Wang H, Xia C, da al. Wani bazuwar, makafi biyu, gwajin gwajin wuribo na probiotics don rage tsananin mucositis na baka wanda chemoradiotherapy ya haifar ga marasa lafiya da nasopharyngeal carcinoma. Ciwon daji. 2019; 125: 1081-1090. Duba m.
  18. Inoue T, Kobayashi Y, Mori N, et al. Hanyoyin haɗakar haɓakar bifidobacteria da horarwa akan juriya akan aiki na fahimi, haɗin jiki da halaye na hanji na batutuwa tsofaffi masu lafiya. Fananan Microbes. 2018; 9: 843-853. Duba m.
  19. Dimidi E, Zdanaviciene A, Christodoulides S, et al. Gwajin asibiti da bazuwar: Bifidobacterium lactis NCC2818 probiotic vs placebo, da tasiri kan lokacin wucewa na hanji, bayyanar cututtuka, da gut microbiology a cikin maƙarƙashiya na yau da kullun. Aliment Pharmacol Ther. 2019; 49: 251-264. Duba m.
  20. Caglar E. Tasirin Bifidobacterium bifidum mai dauke da yoghurt akan kwayoyin cuta na hakori a cikin yara. J Clin Pediatr Dent. 2014; 38: 329-32. Duba m.
  21. Zhang J, Ma S, Wu S, Guo C, Long S, Tan H. Sakamakon ofarin Probiotic a cikin Mata masu ciki tare da Ciwon Cutar Ciwon ciki Mellitus: Binciken Tsare-tsare da Meta-Analysis na omaddara Gwajin gwaji. J Ciwon sukari Res. 2019; 2019: 5364730. Duba m.
  22. Slykerman RF, Kang J, Van Zyl N, et al. Amfani da ƙarin maganin rigakafi na farko akan ƙuruciya ta yara, ɗabi'a da ɗabi'a bazuwar, gwajin sarrafa wuribo. Dokar Paediatr. 2018; 107: 2172-2178. Duba m.
  23. Schmidt RM, Pilmann Laursen R, Bruun S, et al. Labaran duniya Magungunan rigakafi a ƙarshen ƙuruciya suna rage tasirin eczema: Gwajin gwajin da bazuwar. Pediatr Allergy Immunol. 2019; 30: 335-340. Duba m.
  24. Linn YH, Thu KK, Win NHH. Hanyoyin Magungunan rigakafi don Rigakafin Ciwon Ruwa mai Ruwa mai Ruwa a tsakanin Marasa Cutar Marasa Cutar mahaifa: Nazarin Gudanar da Bugun-Biyu mai Ruwa-biyu. Probiotics Antimicrob Sunadaran. 2019; 11: 638-647. Duba m.
  25. Callaway LK, McIntyre HD, Barrett HL, da sauransu. Magungunan rigakafi don Rigakafin Ciwon sukari na Mellitus a cikin Mata masu Kiba da Kiba: Bincike Daga SPRING Double-Blind Randomized Control Control. Ciwon suga. 2019; 42: 364-371. Duba m.
  26. Staudacher HM, Lomer MCE, Farquharson FM, et al. Aarancin Abinci a FODMAPs Yana Rage Cutar cututtuka a Marasa lafiya Tare da Ciwon Bowunƙarar Cikin hanji da Probiotic Maido da nau'ikan Bifidobacterium: Gwajin Tsarin Gudanar da Balaguro. Gastroenterology. 2017; 153: 936-947. Duba m.
  27. Matsuoka K, Uemura Y, Kanai T, et al. Inganci na Bifidobacterium breve Milk mai ƙanshi a cikin Kula da Gusar da Ciwon Cutar Ulcerative. Dig Dis Sci. 2018; 63: 1910-1919. Duba m.
  28. Liu J, Huang XE. Inganci na Bifidobacterium tetragenous mai amfani kwayoyin allunan ga marasa lafiya masu cutar kansa tare da maƙarƙashiyar aiki. Asia Pac J Ciwon Cancer. 2014; 15: 10241-4. Duba m.
  29. Lau AS, Yanagisawa N, Hor YY, et al. Bifidobacterium longum BB536 ya sauƙaƙe cututtukan sama da ƙananan ƙwayoyin microbiota a cikin ƙananan makarantun Malaysia. Fananan Microbes. 2018; 9: 61-70. Duba m.
  30. Ibarra A, Latreille-Barbier M, Donazzolo Y, Pelletier X, Ouwehand AC. Illolin kwanaki 28 na Bifidobacterium animalis subp. lactis HN019 kari kan lokacin wucewar ciki da alamomin ciki a cikin manya tare da maƙarƙashiyar aiki:-makafi mai sau biyu, bazuwar wuri, mai sarrafa wuribo, da kuma gwajin gwaji iri-iri. Gut Microbes. 2018; 9: 236-251. Duba m.
  31. Guardamagna O, Amaretti A, Puddu PE, et al. Arin Bifidobacteria: tasiri akan bayanan martaba na plasma a cikin yara masu lalata. Gina Jiki. 2014; 30 (7-8): 831-6. Duba m.
  32. Badehnoosh B, Karamali M, Zarrati M, et al. Abubuwan da ke haifar da karin kwayar cutar akan masu amfani da kwayoyin halitta na kumburi, danniya da kuma sakamakon ciki a cikin ciwon sukari na ciki. J Matern Fetal Neonatal Med. 2018 Mayu; 31: 1128-1136. Duba m.
  33. Dickerson F, Adamos M, Katsafanas E, et al. Microananan kwayoyin halittu masu kariya don hana sake farfadowa da marasa lafiya tare da ciwon mania mai tsanani: Gwajin gwajin da bazuwar. Maganin Bipolar. 2018 Apr 25. Duba m.
  34. Pinto GS, Cenci MS, Azevedo MS, Epifanio M, Jones MH. Tasirin yogurt mai dauke da Bifidobacterium animalis subsp. lactis DN-173010 probiotic akan dattako da haƙori a cikin marasa lafiyan. Caries Sakamakon. 2014; 48: 63-8. Duba m.
  35. Zamani B, Golkar HR, Farshbaf S, et al. Magungunan asibiti da maganin rayuwa zuwa ƙarin probiotic a cikin marasa lafiya tare da cututtukan zuciya na rheumatoid: bazuwar, makafi biyu, gwajin sarrafa wuribo. Int J Rheum Dis 2016; 19: 869-79. Duba m.
  36. Pinto-Sanchez MI, Hall GB, Ghajar K, et al. Probiotic Bifidobacterium longum NCC3001 yana rage yawan damuwa kuma yana canza aikin kwakwalwa: binciken matukin jirgi a cikin marasa lafiya da cututtukan hanji. Gastroenterology 2017; 153: 448-459.e8. Duba m.
  37. Karamali M, Dadkhah F, Sadrkhanlou M, et al. Hanyoyin karin kwayoyi akan sarrafa glycemic da bayanan lipid a cikin ciwon ciki na ciki: bazuwar, makafi biyu, gwajin sarrafa wuribo. Ciwon sukari Metab 2016; 42: 234-41. Duba m.
  38. Jäger R, Purpura M, Dutse JD, et al. Probiotic Streptococcus thermophilus FP4 da Bifidobacterium breve BR03 haɓaka haɓaka haɓaka haɓaka da kewayon-motsi-motsi bayan aikin lalata tsoka. Kayan abinci na 2016; 8. yawa: E642. Duba m.
  39. Whorwell PJ, Altringer L, Morel J, et al. Fficarancin ingancin kwayar cutar Bifidobacterium infantis 35624 a cikin mata masu fama da cututtukan hanji. Am J Gastroenterol. 2006 Jul; 101: 1581-90. Duba m.
  40. Lau CS, Chamberlain RS. Magungunan rigakafi suna da tasiri wajen hana gudawa mai alaƙa da Clostridium mai wuya: nazari na yau da kullun da meta-bincike. Int J Gen Med. 2016; 9: 27-37. Duba m.
  41. Stenman LK, Lehtinen MJ, Meland N, da sauransu. Probiotic Tare da ko Ba tare da Gudanar da Fiber yana Gudanar da Fat Fat, Haɗa tare da Serum Zonulin, a cikin weightwayar Adwayar Mutane da Obara Adalci-Bazuwar Rarraba Gwajin. EBioMedicine 2016; 13: 190-200. Duba m.
  42. Sato S, Uchida T, Kuwana S, et al. Bacteremia wanda Bifidobacterium breve ya haifar dashi a cikin jariri tare da cloacal exstrophy. Pediatr Int. 2016; 58: 1226-8. Duba m.
  43. Jayasimhan S, Yap NY, Roest Y, Rajandram R, Chin KF. Inganci na shirye-shiryen ƙwayoyin ƙwayoyin ƙwayoyin cuta don inganta maƙarƙashiya mai ɗorewa: bazuwar, makafi biyu, gwajin sarrafa wuribo. Neman Nutr 2013; 32: 928-34. Duba m.
  44. Han K, Wang J, Seo JG, Kim H. Inganci na maganin rigakafi mai ruɓi biyu don cututtukan hanji mai haɗari: gwajin gwagwarmaya mai makafi biyu. J Gastroenterol. 2017; 52: 432-443. Duba m.
  45. Chang HY, Chen JH, Chang JH, Lin HC, Lin CY, Peng CC. Magungunan maganin rigakafi da yawa sun zama mafi ingancin maganin rigakafin rigakafin cutar necrotizing enterocolitis da mace-mace: An sabunta meta-bincike. Koma Daya. 2017; 12: e0171579. Duba m.
  46. Bastürk A, Artan R, Yilmaz A. Inganci na synbiotic, probiotic, da kuma maganin rigakafi don cututtukan hanji a cikin yara: Gwajin gwajin da bazuwar. Turk J Gastroenterol 2016; 27: 439-43. Duba m.
  47. Blaabjerg S, Artzi DM, Aabenhus R. Magungunan rigakafi don Rigakafin cututtukan rigakafin rigakafin cututtukan rigakafi a cikin marasa lafiya - Nazarin Tsaro da Meta-Analysis. Magungunan rigakafi (Basel). 2017; 6. Duba m.
  48. Al Faleh K, Anabrees J. Probiotics don rigakafin necrotizing enterocolitis a cikin yara mata masu zuwa. Cochrane Database Syst Rev. 2014;: CD005496. Duba m.
  49. Dimidi E, Christodoulides S, Fragkos KC, Scott SM, Whelan K. Sakamakon probiotics a kan maƙarƙashiyar aiki a cikin manya: nazari na yau da kullun da ƙididdigar gwajin gwaji da bazuwar. Am J Clin Nutr. 2014; 100: 1075-84. Duba m.
  50. Wildt S, Nordgaard I, Hansen U, Brockmann E, Rumessen JJ. Gwajin gwajin-wuri mai sau biyu mai rikitarwa tare da Lactobacillus acidophilus La-5 da Bifidobacterium animalis subsp. lactis BB-12 don kiyayewa gafara a cikin ulcerative colitis. J Crohns Colitis 2011; 5: 115-21. Duba m.
  51. Shen J, Zuo ZX, Mao AP. Hanyoyin maganin rigakafi akan haifar da gafara da kiyaye farfajiya a cikin ulcerative colitis, cututtukan Crohn, da pouchitis: meta-bincike na gwajin gwaji da bazuwar. Lamunƙarar Cikin Cikin Dis. 2014; 20: 21-35. Duba m.
  52. Park MS, Kwon B, Ku S, Ji GE4. Amfani da Bifidobacterium longum BORI da Lactobacillus acidophilus AD031 Probiotic Jiyya a jarirai tare da Rotavirus Kamuwa da cuta. Kayan abinci. 2017; 9. pii: E887. Duba m.
  53. Søndergaard B, Olsson J, Ohlson K, Svensson U, Bytzer P, Ekesbo R. Hanyoyin madara mai narkewa akan ƙwayoyin cuta da fure na hanji a cikin marasa lafiya masu fama da cututtukan hanji: bazuwar, gwajin gwajin wuribo Scand J Gastroenterol 2011; 46: 663-72. Duba m.
  54. Simrén M, Ohman L, Olsson J, et al. Gwajin asibiti: tasirin madara mai narkewa dauke da kwayar cuta guda uku a cikin marasa lafiya da ke fama da ciwon hanji - bazuwar, makafi biyu, nazarin sarrafawa. Aliment Pharmacol Ther 2010; 31: 218-27. Duba m.
  55. Goldenberg JZ, Lytvyn L, Steurich J, Parkin P, Mahant S, Johnston BC. Magungunan rigakafi don rigakafin cututtukan yara masu alaƙa da cututtukan yara. Cochrane Database Syst Rev. 2015;: CD004827. Duba m.
  56. O'Callaghan A, van Sinderen D. Bifidobacteria da Matsayinsu a Matsayin Membobin Gan Adam Gut Microbiota. Microbiol na gaba. 2016 Jun 15; 7: 925. Duba m.
  57. Olivares M, Castillejo G, Varea V, Sanz Y. Ya ce;Makafi guda biyu, bazuwar, gwajin shiga cikin wuribo don kimanta sakamakon Bifidobacterium longum CECT 7347 a cikin yara tare da sabon cututtukan celiac. Br J Nutr. 2014 Jul 14; 112: 30-40. Duba m.
  58. Hojsak I, Tokic Pivac V, Mocic Pavic A, Pasini AM, Kolacek S. Bifidobacterium animalis subsp. lactis ya kasa hana kamuwa da cututtuka na yau da kullun a cikin yara asibiti: bazuwar, makafi biyu, binciken sarrafa wuribo. Am J Clin Nutr. 2015 Mar; 101: 680-4. Duba m.
  59. Eskesen D, Jespersen L, Michelsen B, Whorwell PJ, Müller-Lissner S, Morberg CM. Sakamakon kwayar cutar kwayar cutar Bifidobacterium animalis subsp. lactis, BB-12®, akan yawan yin najasa a cikin batutuwa masu lafiya tare da karancin saurin najasa da rashin jin daɗin ciki: bazuwar, makafi biyu, sarrafa wuribo, gwajin rukuni-rukuni Br J Nutr. 2015 Nuwamba 28; 114: 1638-46. Duba m.
  60. Costeloe K, Hardy P, Juszczak E, Wilks M, Millar MR; Magungunan rigakafi a cikin Studyungiyar Nazarin Studyungiyar Studyananan yara. Bifidobacterium breve BBG-001 a cikin ƙananan yara ƙanana: tsarin gwajin 3 na bazuwar sarrafawa. Lancet. 2016 Feb 13; 387: 649-60. Duba m.
  61. Allen SJ, Wareham K, Wang D, Bradley C, Hutchings H, Harris W, Dhar A, Brown H, Foden A, Gravenor MB, Mack D. Lactobacilli da bifidobacteria a cikin rigakafin cututtukan cututtukan kwayoyin cuta da Clostridium mai fama da zawo a cikin tsofaffi marasa lafiya (PLACIDE): bazuwar, makafi biyu, wurin sarrafa wuribo, gwaji da yawa. Lancet. 2013 Oktoba 12; 382: 1249-57. Duba m.
  62. Roberfroid MB. Magungunan rigakafi da maganin rigakafi: shin abinci ne masu aiki? Am J Clin Nutr. 2000; 71 (Gudanar da 6): 1682S-7S; tattaunawa 1688S-90S. Duba m.
  63. Wang YH, Huang Y. Sakamakon Lactobacillus acidophilus da Bifidobacterium bifidum kari zuwa daidaitaccen maganin sau uku kan kawar da Helicobacter pylori da canje-canje masu saurin canzawa a cikin furen ciki. Duniya J Microbiol Biotechnol. 2014; 30: 847-53. Duba m.
  64. Wang ZH, Gao QY, Fang JY. Meta-bincike na inganci da amincin maganin Lactobacillus mai dauke da Bifidobacterium mai dauke da kwayar probiotic a cikin maganin kawar da Helicobacter pylori. J Gastroenterol. 2013; 47: 25-32. Duba m.
  65. Videlock EJ, Cremonini F. Meta-bincike: maganin rigakafi a cikin cututtukan cututtukan kwayoyin cuta. Aliment Pharmacol Ther. 2012; 35: 1355-69. Duba m.
  66. Tomasz B, Zoran S, Jaroslaw W, Ryszard M, Marcin G, Robert B, Piotr K, Lukasz K, Jacek P, Piotr G, Przemyslaw P, Michal D. Amfani da maganin rigakafi na dogon lokaci Lactobacillus da Bifidobacterium suna da tasirin maganin cutar abin da ya faru da tsananin pouchitis: binciken da ake son yi. Kamfanin Biomed Res Int. 2014; 2014: 208064. Duba m.
  67. Shavakhi A, Tabesh E, Yaghoutkar A, Hashemi H, Tabesh F, Khodadoostan M, Minakari M, Shavakhi S, Gholamrezaei A. Sakamakon tasirin kwayar kwayar cuta ta multistrain a kan bismuth mai dauke da kashi hudu na maganin cutar Helicobacter pylori: wani wuri mai sarrafa wuribo sau uku -san hankali. Helicobacter. 2013; 18: 280-4. Duba m.
  68. Rerksuppaphol S, Rerksuppaphol L. Gwajin gwajin gwaji na maganin rigakafi don rage yawan sanyi a cikin ɗaliban makaranta. Pediatr Int. 2012; 54: 682-7. Duba m.
  69. Rautava S, Kainonen E, Salminen S, Isolauri E. Maganin probiotic a lokacin daukar ciki da ciyar da nono yana rage barazanar eczema a cikin jariri. J Rashin lafiyar Clin Immunol. 2012; 130: 1355-60. Duba m.
  70. Langkamp-Henken B, Rowe CC, Ford AL, Christman MC, Nieves C Jr, Khouri L, Specht GJ, Girard SA, Spaiser SJ, Dahl WJ. Bifidobacterium bifidum R0071 yana haifar da mafi girma na kwanakin lafiya da ƙananan kashi na ɗaliban ɗaliban ilimi da ke ba da rahoton ranar sanyi / mura: bazuwar, makafi biyu, nazarin-wuribo. Br J Nutr. 2015; 143: 426-34. Duba m.
  71. Gore C, Custovic A, Tannock GW, Munro K, Kerry G, Johnson K, Peterson C, Morris J, Chaloner C, Murray CS, Woodcock A. Jiyya da kuma rigakafin rigakafin sakandare na maganin rigakafin cutar Lactobacillus paracasei ko Bifidobacterium lactis akan farkon jariri eczema : gwajin gwagwarmaya bazuwar tare da biyo baya har zuwa shekaru 3. Clin Exp lerararrawa 2012; 42: 112-22. Duba m.
  72. Fernández-Carrocera LA, Solis-Herrera A, Cabanillas-Ayón M, Gallardo-Sarmiento RB, García-Pérez CS, Montaño-Rodríguez R, Echániz-Aviles MO. Makafi biyu, gwajin asibiti bazuwar don kimanta ingancin maganin rigakafi a cikin jariran da ba su kai haihuwa ba wanda nauyinsu bai fi 1500 g ba game da rigakafin cutar necrotising enterocolitis. Arch Dis Yarinyar Haihuwar Neonatal Ed 2013; 98: F5-9. Duba m.
  73. Begtrup LM, de Muckadell OB, Kjeldsen J, Christensen RD, Jarbøl DE. Jiyya na dogon lokaci tare da maganin rigakafi a cikin marasa lafiya na farko waɗanda ke fama da cututtukan hanji - bazuwar, makafi biyu, gwajin gwajin wuribo. Scand J Gastroenterol 2013; 48: 1127-35. Duba m.
  74. Allen SJ, Jordan S, Storey M, Thornton CA, Gravenor MB, Garaiova I, Plummer SF, Wang D, Morgan G. Probiotics a cikin rigakafin eczema: gwajin da bazuwar sarrafawa. Arch Dis Yaro 2014; 99: 1014-9. Duba m.
  75. Das RR.Singh M, Shafiq N. Magungunan rigakafi a Jiyya na Rhinitis na rashin lafiyan. Jaridar Alungiyar Allergy ta Duniya ta 2010; 3: 239-244.
  76. Seki M, Igarashi T Fukuda Y Simamura S Kaswashima T Ogasa K. Tasirin Bifidobacterium ya samo madara a kan "tsari" tsakanin tsofaffi. Nutr Abincin 1978; 31: 379-387.
  77. Kageyama T, Nakano Y Tomoda T. Nazarin kwatanci kan Gudanar da Baki na Wasu Shirye-shiryen Bifidobacterium. Magunguna da Biology (Japan) 1987; 115: 65-68.
  78. Kageyama T, Tomoda T Nakano Y. Sakamakon Gudanarwar Bifidobacterium a cikin Marasa lafiya tare da cutar sankarar bargo. Bifidobacteria Microflora. 1984; 3: 29-33.
  79. Ballongue J, Grill J Baratte-Euloge P. Action sur la flore intestinale de laits fermentés au Bifidobacterium. Rage 1993; 73: 249-256.
  80. Ogata T, Kingaku M Yaeshima T Teraguchi S Fukuwatari Y Ishibashi N Hayasawa H Fujisawa T Lino H. Sakamakon aikin Bifidobacterium longum BB536 yogurt akan yanayin hanji na manya masu lafiya. Microb Ecol Lafiya Dis 1999; 11: 41-46.
  81. Tomoda T, Nakano Y Kageyama T. Bambanci a Groupananan sungiyoyi na Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Gudanar da Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Tsarin Harkokin Tsarin Harkokin Tsarin Harkokin Tsarin Harkokin Tsarin Harkokin Tsarin Harkokin Tsarin Harkokin Tsarin Tsarin Tsarin Lafiya da Kayayyaki da Magungunan Immunosuppressive. Magunguna da Biology (Japan) 1981; 103: 45-49.
  82. Tomoda T, Nakano Y Kageyama T. Ciwon Canji na Ciki da cutar Candida a Marasa lafiya tare da cutar sankarar bargo: Tasirin Gudanarwar Bifidobacterium. Bifidobacteria Microflora 1988; 7: 71-74.
  83. Araya-Kojima Tomoko, Yaeshima Tomoko Ishibashi Norio Shimamura Seiichi Hayasawa Hirotoshi. Hanyoyin hana amfani na Bifidobacterium longum BB536 akan cutar Bacteria mai illa. Bifidobacteria Microflora 1995; 14: 59-66.
  84. Namba K, Yaeshima T Ishibashi N Hayasawa H da Yamazaki Shoji. Hanyoyin hanawa na Bifidobacterium longum akan Enterohemorrhagic Escherichia coli O157: H7. Bioscience Microflora 2003; 22: 85-91.
  85. Igarashi M, Iiyama Y Kato R Tomita M Asami N Ezawa I. Sakamakon Bifidobacterium longum da lactulose akan ƙarfin ƙashi a cikin ƙirar ƙirar osteoporosis na ovariectomized. Bifidus 1994; 7: 139-147.
  86. Yaeshima T, Takahashi S Ota S Nakagawa K Ishibashi N Hiramatsu A Ohashi T Hayasawa H Iino H. Tasirin yogurt mai ɗauke da Bifidobacterium longum BB536 kan yawan yin fitsari da halaye na ƙwararrun manya: Kwatantawa da daidaitaccen yanayin yogurt. Kenko Eiyo Shokuhin Kenkyu 1998; 1 (3/4): 29-34.
  87. Yaeshima T, Takahashi S Matsumoto N Ishibashi N Hayasawa H Lino H. Tasirin yogurt mai dauke da Bifidobacterium longum BB536 akan yanayin hanji, halaye masu kyau da yawan bahaya: Kwatantawa da daidaitaccen yogurt. Biosci Microflora 1997; 16: 73-77.
  88. Xiao J, Kondol S Odamaki T Miyaji K Yaeshima T Iwatsuki K Togashi H Benno Y. Tasirin yogurt mai dauke da Bifidobacterium longum BB 536 kan yawan yin bahaya da kuma halaye masu kyau na manya masu lafiya: Giciye mai makafi biyu akan karatu. Jaridar Jafananci na Lactic Acid Bacteria 2007; 18: 31-36.
  89. Yaeshima T, Takahashi S Ogura A Konno T Iwatsuki K Ishibashi N Hayasawa H. Tasirin Madarar Ba-Fulawa Mai Bauke da Bifidobacterium longum BB536 kan theaddamar da Mitar da Feabi'ar calabi'a a Lafiyayyun Manya. Jaridar Abinci na Abinci 2001; 4: 1-6.
  90. Ogata T, Nakamura T Anjitsu K Yaeshima T Takahashi S Fukuwatari Y Ishibashi N Hayasawa H Fujisawa T Iino H. Tasirin aikin Bifidobacterium longum BB536 akan yanayin hanji, yawan bahaya da halaye na mutane masu sa kai. Biosci Microflora 1997; 16: 53-58.
  91. Iwabuchi N, Hiruta N Kanetada S Yaeshima T Iwatsuki K Yasui H. Illolin Gudanar da Intranasal na Bifidobacterium longum BB536 akan Tsarin rigakafi na Mucosal a Cutar Tasa Numfashi da Cutar Mura a Mice. Kimiyyar Milk 2009; 38: 129-133.
  92. Sekine I, Yoshiwara S Homma N Takanori H Tonosuka S. Sakamakon Bifidobacterium dauke da madara akan sinadarin chemiluminescence na leukocytes na gefe kuma yana nufin ƙararrawar ƙwayoyin jinin jini - yiwuwar rawar Bifidobacterium akan kunna macrophages. Magunguna (Japan) 1985; 14: 691-695.
  93. Singh, J., Rivenson, A., Tomita, M., Shimamura, S., Ishibashi, N., da Reddy, BS Bifidobacterium longum, kwayar cutar lactic acid da ke samar da kwayar hanji ta hana kansar ciki kuma ta daidaita matsakaitan masu sayar da kwayoyin halittar hanji . Carcinogenesis 1997; 18: 833-841. Duba m.
  94. Reddy, B. S. da Rivenson, A. Tasirin hanawa na Bifidobacterium longum a kan hanji, mammary, da hanta carcinogenesis wanda 2-amino-3-methylimidazo [4,5-f] quinoline ya haifar, mutagen abinci. Ciwon daji Res. 9-1-1993; 53: 3914-3918. Duba m.
  95. Yamazaki, S., Machii, K., Tsuyuki, S., Momose, H., Kawashima, T., da Ueda, K. Magungunan rigakafi game da haɗin Bifidobacterium longum tare da alaƙar su da rigakafin mamayewar ƙwayoyin cuta. Immunology na 1985; 56: 43-50. Duba m.
  96. Kondo, J., Xiao, J. Z., Shirahata, A., Baba, M., Abe, A., Ogawa, K., da Shimoda, T. Hanyoyin gyare-gyare na Bifidobacterium longum BB536 kan lalata cikin tsofaffin marasa lafiya da ke karɓar abinci na ciki. Duniya J Gastroenterol 4-14-2013; 19: 2162-2170. Duba m.
  97. Akatsu, H., Iwabuchi, N., Xiao, JZ, Matsuyama, Z., Kurihara, R., Okuda, K., Yamamoto, T., da Maruyama, M. Magungunan Clinical na Probiotic Bifidobacterium longum BB536 akan aikin rigakafi da Microbiota na hanji a cikin tsofaffin Marasa lafiya Masu karɓar Ciyarwar Tube ntearfafawa. JPEN J Parenter Ingantaccen Nutr 11-27-2012; Duba m.
  98. Odamaki, T., Sugahara, H., Yonezawa, S., Yaeshima, T., Iwatsuki, K., Tanabe, S., Tominaga, T., Togashi, H., Benno, Y., da Xiao, JZ Effect na shan yogurt na baka wanda ya kunshi Bifidobacterium longum BB536 akan lambobin kwayar cutar enterotoxigenic Bacteroides fragilis a cikin microbiota. Anaerobe. 2012; 18: 14-18. Duba m.
  99. Iwabuchi, N., Xiao, J. Z., Yaeshima, T., da Iwatsuki, K. Gudanar da baki na Bifidobacterium longum yana inganta cutar kwayar cutar a cikin beraye. Biol.Pharm.Bull. 2011; 34: 1352-1355. Duba m.
  100. Simakachorn, N., Bibiloni, R., Yimyaem, P., Tongpenyai, Y., Varavithaya, W., Grathwohl, D., Reuteler, G., Maire, JC, Blum, S., Steenhout, P., Benyacoub , J., da Schiffrin, Haƙuri na EJ, aminci, da tasiri a kan faecal microbiota na wani tsari wanda aka ƙaddara tare da pre-da probiotics a cikin yara marasa lafiya. J Pediatr.Gastroenterol.Nutr. 2011; 53: 174-181. Duba m.
  101. Hascoet, J. M., Hubert, C., Rochat, F., Legagneur, H., Gaga, S., Emady-Azar, S., da Steenhout, P. G. Tasirin abin da aka kirkira kan ci gaban karamin hanji microbiota. J Pediatr.Gastroenterol.Nutr. 2011; 52: 756-762. Duba m.
  102. Firmansyah, A., Dwipoerwantoro, P. G., Kadim, M., Alatas, S., Conus, N., Lestarina, L., Bouisset, F., da Steenhout, P. Ingantaccen haɓakar yara masu tasowa sun ciyar da madara mai ƙunshe da abubuwan haɗin kai. Asia Pac.J Clin.Nutr. 2011; 20: 69-76. Duba m.
  103. Tang, M. L., Lahtinen, S. J., da Boyle, R. J. Probiotics da prebiotics: tasirin asibiti a cikin cututtukan rashin lafiyan. Curr.Opin.Pediatr. 2010; 22: 626-634. Duba m.
  104. Namba, K., Hatano, M., Yaeshima, T., Takase, M., da Suzuki, K. Sakamakon Bifidobacterium longum BB536 na gudanarwa akan kamuwa da cutar mura, maganin rigakafi na rigakafi na mura, da kuma rigakafin shiga tsakani a cikin tsofaffi. Biosci.Biotechnol.Biochem. 2010; 74: 939-945. Duba m.
  105. Gianotti, L., Morelli, L., Galbiati, F., Rocchetti, S., Coppola, S., Beneduce, A., Gilardini, C., Zonenschain, D., Nespoli, A., da Braga, M. Gwajin makafi biyu da bazuwar akan tsarin gudanarwar maganin rigakafi a cikin marasa lafiyar cututtukan ciki. Duniya J Gastroenterol. 1-14-2010; 16: 167-175. Duba m.
  106. Andrade, S. da Borges, N. Tasirin madara mai narkewa dauke da Lactobacillus acidophilus da Bifidobacterium longum akan lemun plasma na mata tare da ingantaccen cholesterol na al'ada ko matsakaici. J.Dairy Res. 2009; 76: 469-474. Duba m.
  107. Rouge, C., Piloquet, H., Butel, MJ, Berger, B., Rochat, F., Ferraris, L., Des, Robert C., Legrand, A., de la Cochetiere, MF, N'Guyen, JM, Vodovar, M., Voyer, M., Darmaun, D., da Roze, JC ralarin baka tare da maganin rigakafi a cikin ƙananan ƙananan ƙananan ƙananan yara: bazuwar, makafi biyu, gwajin sarrafa wuribo. Am J J.Nutr. 2009; 89: 1828-1835. Duba m.
  108. Iwabuchi, N., Takahashi, N., Xiao, JZ, Yonezawa, S., Yaeshima, T., Iwatsuki, K., da Hachimura, S. effectsarfafa tasirin Bifidobacterium longum akan samar da ƙwayoyin cuta na Th2 masu jan hankali tare da T cell-antigen-gabatarwar kwayar halitta FEMS Immunol.Med.Microbiol. 2009; 55: 324-334. Duba m.
  109. Takeda, Y., Nakase, H., Namba, K., Inoue, S., Ueno, S., Uza, N., da Chiba, T. readdamar da T-bet da ƙananan mahaɗan mahaɗan ta hanyar Bifidobactrium longum yana inganta kumburin ciki na ulcerative colitis. Lamararrawa.Bowel.Dis. 2009; 15: 1617-1618. Duba m.
  110. Soh, SE, Aw, M., Gerez, I., Chong, YS, Rauff, M., Ng, YP, Wong, HB, Pai, N., Lee, BW, da Shek, LP Probiotic supplementation a farkon 6 watanni na rayuwa cikin haɗarin jarirai na Asiya - tasiri akan eczema da kuma fahimtar atopic yana da shekara 1. Clin Clinic. 2009; 39: 571-578. Duba m.
  111. Odamaki, T., Xiao, JZ, Sakamoto, M., Kondo, S., Yaeshima, T., Iwatsuki, K., Togashi, H., Enomoto, T., da Benno, Y. Rarraba nau'ikan nau'ikan Bacteroides fragilis rukuni a cikin mutane tare da itacen al'ul na Japan. Appl. Yanayi.Microbiol. 2008; 74: 6814-6817. Duba m.
  112. del Giudice, M. M. da Brunese, F. P. Probiotics, prebiotics, da rashin lafiyan yara: menene sabo a shekarar da ta gabata? J Jarin Gastroenterol. 2008; 42 Gudanar da 3 Pt 2: S205-S208. Duba m.
  113. Chouraqui, JP, Grathwohl, D., Labaune, JM, Hascoet, JM, de, Montgolfier, I, Leclaire, M., Giarre, M., da Steenhout, P. Bincike na aminci, haƙuri, da tasirin kariya daga gudawa na ƙananan yara waɗanda ke ƙunshe da haɗuwa na maganin rigakafi ko maganin rigakafi da prebiotics a cikin gwajin gwajin bazuwar. Am J J.Nutr. 2008; 87: 1365-1373. Duba m.
  114. Matsumoto, T., Ishikawa, H., Tateda, K., Yaeshima, T., Ishibashi, N., da Yamaguchi, K. Gudanar da baka na Bifidobacterium longum yana hana ƙwayar Pseudomonas aeruginosa sepsis a cikin beraye. J Appl Mikrobiol. 2008; 104: 672-680. Duba m.
  115. Odamaki, T., Xiao, JZ, Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, T., da Benno, Y. Tasirin Bifidobacterium longum BB536 a kan faecal microbiota a cikin mutane tare da itacen al'ul na Japan a lokacin lokacin fure. J Likitan Mikrobiol. 2007; 56 (Pt 10): 1301-1308. Duba m.
  116. Iwabuchi, N., Takahashi, N., Xiao, J. Z., Miyaji, K., da Iwatsuki, K. In vitro Th1 cytokine mai zaman kanta Th2 danniyar tasirin bifidobacteria. Microbiol.Immunol. 2007; 51: 649-660. Duba m.
  117. Xiao, JZ, Kondo, S., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., da Enomoto, T. Canje-canje a cikin matakan TARC na jini a lokacin itacen al'ul na kasar Japan da dangantaka tare da ci gaban bayyanar cututtuka. Int.Arch.Cutar Allergy Immunol. 2007; 144: 123-127. Duba m.
  118. Odamaki, T., Xiao, JZ, Iwabuchi, N., Sakamoto, M., Takahashi, N., Kondo, S., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, T., da Benno, Y. Canjin canji na ƙananan ƙwayoyin cuta a cikin mutane tare da itacen al'ul na ƙasar Japan a lokacin lokacin fure da tasirin tasirin probiotic. J Bincike. Allergol.Clin.Immunol. 2007; 17: 92-100. Duba m.
  119. Xiao, JZ, Kondo, S., Yanagisawa, N., Miyaji, K., Enomoto, K., Sakoda, T., Iwatsuki, K., da Enomoto, T. Ingancin aikin asibiti na kwayar cutar Bifidobacterium mai dorewa don maganin cututtuka na itacen al'ul na ƙasan itacen al'adun Japan a cikin batutuwan da aka kimanta a cikin sashin ɗaukar muhalli. Allergol.Int. 2007; 56: 67-75. Duba m.
  120. Puccio, G., Cajozzo, C., Meli, F., Rochat, F., Grathwohl, D., da Steenhout, P. Gwajin asibiti na sabon tsarin kirkirar jarirai masu dauke da rayayyiyar Bifidobacterium longum BL999 da prebiotics. Gina Jiki 2007; 23: 1-8. Duba m.
  121. Xiao, JZ, Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Miyaji, K., Iwatsuki, K., Togashi, H., Enomoto, K., da Enomoto, T. Probiotics a cikin maganin cedar pollinosis na Japan: fitina mai ɗorewa ta wuribo sau biyu. Clin Clinic. 2006; 36: 1425-1435. Duba m.
  122. Xiao, JZ, Kondo, S., Yanagisawa, N., Takahashi, N., Odamaki, T., Iwabuchi, N., Iwatsuki, K., Kokubo, S., Togashi, H., Enomoto, K., da Enomoto, T. Tasirin probiotic Bifidobacterium longum BB536 [ya gyara] a sauƙaƙe alamun asibiti da kuma daidaita matakan cytokine na plasma na itacen cedar pollinosis na Japan yayin lokacin fure. Makauniyar makafi biyu, gwajin sarrafa wuribo. J Bincike. Allergol.Clin.Immunol. 2006; 16: 86-93. Duba m.
  123. Bennet, R., Nord, C. E., da Zetterstrom, R. Tsarin mulkin mallaka na hanji na sabbin jarirai ta hanyar gudanar da bifidobacteria da lactobacilli. Dokar Paediatr. 1992; 81: 784-787. Duba m.
  124. Zsivkovits, M., Fekadu, K., Sontag, G., Nabinger, U., Huber, WW, Kundi, M., Chakraborty, A., Foissy, H., da Knasmuller, S. Rigakafin heterocyclic amine-jawo Lalacewar DNA a cikin hanta da hanta bera ta wasu lactobacillus iri. Carcinogenesis 2003; 24: 1913-1918. Duba m.
  125. Orrhage, K., Sjostedt, S., da Nord, C. E. Sakamakon kari tare da kwayoyin lactic acid da oligofructose akan microflora na hanji yayin gudanar da aikin cefpodoxime proxetil. J Antimicrob.Wani shugaba. 2000; 46: 603-612. Duba m.
  126. Xiao JZ, Takahashi S, Odamaki T, et al. Kwayar cututtukan cututtukan cututtukan bifidobacterial da aka rarraba a kasuwar Japan.Biosci Biotechnol Biochem. 2010; 74: 336-42. Duba m.
  127. AlFaleh K, Anabrees J, Bassler D, Al-Kharfi T. Probiotics don rigakafin necrotizing enterocolitis a cikin yara mata masu ciki. Cochrane Database na Tsare-tsaren Tsare-tsaren 2011, Issue 3. Art. A'a.: CD005496. DOI: 10.1002 / 14651858.CD005496.pub3. Duba m.
  128. Tabbers MM, Milliano I, Roseboom MG, Benninga MA. Shin Bifidobacterium breve yana da tasiri wajen magance ƙyamurin ciki? Sakamako daga binciken matukin jirgi. Nutr J 2011; 10: 19. Duba m.
  129. Leyer GJ, Li S, Mubasher ME, et al. Hanyoyin rigakafi akan sanyi da mura-kamar alamun bayyanar cututtuka da tsawon lokacin yara. Ilimin yara na yara 2009; 124: e172-e179. Duba m.
  130. Miele E, Pascarella F, Giannetti E. et al. Hanyoyin shirye-shiryen rigakafi (VSL # 3) akan shigar da gyara gafara ga yara tare da ulcerative colitis. Am J Gastroenterol 2009; 104: 437-43. Duba m.
  131. Kuhbacher T, Ott SJ, Helwig U, et al. Kwayar cuta da fungal microbiota dangane da maganin probiotic (VSL # 3) a cikin pouchitis. Gut 2006; 55: 833-41. Duba m.
  132. Bibiloni R, Fedorak RN, Tannock GW, et al. VSL # 3 probiotic-cakuda yana haifar da gafara a marasa lafiya tare da aiki ulcerative colitis. Am J Gastroenterol 2005; 100: 1539-46. Duba m.
  133. Tursi A, Brandimarte G, Giorgetti GM, et al. Saananan balsalazide tare da shirye-shiryen probiotic mai ƙarfi sosai ya fi tasiri fiye da balsalazide shi kaɗai ko mesalazine a cikin maganin mummunan ulcerative ulcerative colitis. Med Sci Monit 2004; 10: PI126-31. Duba m.
  134. Kato K, Mizuno S, Umesaki Y, et al. Gwajin gwajin wuribo da bazuwar tantance tasirin madarar bifidobacteria-fermented on ulcerative colitis. Aliment Pharmacol Ther 2004; 20: 1133-41. Duba m.
  135. McFarland LV. Meta-bincike na maganin rigakafi don rigakafin cututtukan cututtukan kwayoyin da ke hade da cutar Clostridium mai wahala. Am J Gastroenterol 2006; 101: 812-22. Duba m.
  136. O'Mahony L, McCarthy J, Kelly P, et al. Lactobacillus da bifidobacterium a cikin cututtukan jijiyoyin hanji: amsoshin bayyanar cututtuka da dangantaka da bayanan cytokine. Gastroenterology 2005; 128: 541-51. Duba m.
  137. Ishikawa H, Akedo I, Umesaki Y, et al. Gwajin gwajin da bazuwar sakamakon tasirin madarar-fised-fermented on ulcerative colitis. J Am Coll Nutr 2003; 22: 56-63. Duba m.
  138. Rastall RA. Kwayar cuta a cikin hanji: abokai da abokan gaba da yadda ake canza daidaituwa. J Nutr 2004; 134: 2022S-2026S. Duba m.
  139. Mimura T, Rizzello F, Helwig U, et al. Sau ɗaya a kullum babban maganin probiotic far (VSL # 3) don ci gaba da gafara cikin maimaitawa ko ƙin pouchitis. Gut 2004; 53: 108-14. Duba m.
  140. Cremonini F, Di Caro S, Covino M, et al. Hanyoyin shirye-shiryen maganin rigakafi daban-daban akan cututtukan cututtukan da ke tattare da maganin hawan-kumburi: haɗuwa da rukuni guda, makafi sau uku, binciken sarrafa wuribo. Am J Gastroenterol 2002; 97: 2744-9. Duba m.
  141. Sullivan A, Barkholt L, Nord CE. Lactobacillus acidophilus, Bifidobacterium lactis da Lactobacillus F19 suna hana rikice-rikicen muhalli masu alaƙa da kwayoyin Bacteroides fragilis a cikin hanji. J Antimicrob Cheamma 2003; 52: 308-11. Duba m.
  142. Kim HJ, Camilleri M, McKinzie S, et al. Gwajin gwajin da aka samu na kwayar cuta, VSL # 3, akan wucewar hanji da alamomi a cikin gudawa-mafi yawan cututtukan hanji. Aliment Pharmacol Ther 2003; 17: 895-904. . Duba m.
  143. Roberfroid MB. Magungunan rigakafi da maganin rigakafi: shin abinci ne masu aiki? Am J Clin Nutr 2000; 71: 1682S-7S. Duba m.
  144. Gionchetti P, Rizzello F, Venturi A, et al. Magungunan maganin baka kamar maganin kulawa a cikin marasa lafiya tare da cutar pouchitis na yau da kullun: makafi biyu, gwajin sarrafa wuribo. Gastroenterology 2000; 119: 305-9. Duba m.
  145. Rautio M, Jousimies-Somer H, Kauma H, et al. Ciwon hanta saboda Lactobacillus rhamnosus iri wanda ba za a iya rarrabe shi daga L. rhamnosus iri GG. Clin Infect Dis 1999; 28: 1159-60. Duba m.
  146. Goldin BR. Amfanin Lafiya na maganin rigakafi. Br J Nutr 1998; 80: S203-7. Duba m.
  147. Kalima P, Masterton RG, Roddie PH, et al. Lactobacillus rhamnosus kamuwa da cuta a cikin yaro mai biyo bayan ɓarkewar kasusuwa. J Cutar 1996; 32: 165-7. Duba m.
  148. Saxelin M, Chuang NH, Chassy B, et al. Lactobacilli da bakteriya a kudancin Finland 1989-1992. Clin Infect Dis 1996; 22: 564-6. Duba m.
  149. Lewis SJ, Freedman AR. Bayanin sake dubawa: amfani da jami'ai masu amfani da maganin rigakafi da maganin cututtukan ciki. Aliment Pharmacol Ther 1998; 12: 807-22. Duba m.
  150. Meydani SN, Ha WK. Immunologic sakamakon yogurt. Am J Clin Nutr 2000; 71: 861-72. Duba m.
  151. Isolauri E, Arvola T, Sutas Y, et al. Probiotics a cikin gudanar da atopic eczema. Clin Exp Allergy 2000; 30: 1604-10. Duba m.
  152. Korschunov VM, Smeyanov VV, Efimov BA, et al. Amfani da magani na shirin Bifidobacterium mai jure kwayoyin cuta cikin maza da aka fallasa zuwa gamma-irradiation mai girma. J Med Microbiol 1996; 44: 70-4. Duba m.
  153. Venturi A, Gionchetti P, Rizzello F, da sauransu. Tasiri kan abun da ke cikin fure na faecal flora ta sabon shirye-shiryen rigakafi: bayanan farko game da kulawar marasa lafiya da ulcerative colitis. Aliment Pharmacol Ther 1999; 13: 1103-8. Duba m.
  154. Phuapradit P, Varavithya W, Vathanophas K, da al. Rage kamuwa da cuta na rotavirus a cikin yara masu karɓar fom mai amfani da bifidobacteria. J Med Assoc Thai 1999; 82: S43-8. Duba m.
  155. Hoyos AB. Rage tasirin cutar necrotizing enterocolitis da ke hade da gudanarwar cikin gida na Lactobacillus acidophilus da Bifidobacterium infantis zuwa jarirai a cikin sashen kulawa na musamman. Int J Infect Dis 1999; 3: 197-202. Duba m.
  156. Pierce A. Pharmungiyar Magungunan Magunguna ta Amurka Jagorar Amfani ga Magunguna ta Naturalasa. New York: Jaridar Stonesong, 1999: 19.
  157. Chen RM, Wu JJ, Lee SC, da sauransu. Ofara yawan Bifidobacterium na hanji da danniya na ƙwayoyin cuta na coliform tare da cin gajiyar yogurt na ɗan gajeren lokaci. J Cutar Sci 1999: 82: 2308-14. Duba m.
  158. Ha GY, Yang CH, Kim H, Chong Y. Batun tabin hankali wanda Bifidobacterium longum ya haifar. J Jarin Microbiol 1999; 37: 1227-8. Duba m.
  159. Colombel JF, Cortot A, Neut C, Romond C. Yoghurt tare da Bifidobacterium longum yana rage tasirin tasirin ciki na erythromycin. Lancet 1987; 2: 43.
  160. Hirayama K, Rafter J. Matsayi na kwayar cutar kwayar cuta a cikin rigakafin cutar kansa. Microbes ya kamu da cutar 2000; 2: 681-6. Duba m.
  161. Macfarlane GT, Cummings JH. Magungunan rigakafi da rigakafi: shin iya daidaita ayyukan ƙwayoyin cuta na hanji zai amfani lafiyar su? BMJ 1999; 318: 999-1003. Duba m.
  162. Chiang BL, Sheih YH, Wang LH, et al. Haɓaka rigakafi ta amfani da abinci mai amfani da kwayar cutar lactic acid (Bifidobacterium lactis HN019): ingantawa da ma'anar maganganun ƙwayoyin salula. Eur J Clin Nutr 2000; 54: 849-55. Duba m.
  163. Lievin V, Peiffer I, Hudault S, et al. Bifidobacterium damuwa daga mazaunin jariri mai ciki na microflora yana yin aikin maganin antimicrobial. Gut 2000; 47: 646-52. Duba m.
  164. Arunachalam K, Gill HS, Chandra RK. Hanara ƙarfin aikin rigakafin halitta ta hanyar cin abincin Bifidobacterium lactis (HN019). Eur J Clin Nutr 2000; 54: 263-7. Duba m.
  165. Bouhnik Y, Pochart P, Marteau P, et al. Faɗakarwa ta hanzari a cikin mutane na ingantaccen bifidobacterium wanda aka sha a madara mai ƙanshi. Gastroenterology 1992; 102: 875-8. Duba m.
  166. Saavedra JM, et al. Ciyar da bifidobacterium bifidum da streptococcus thermophilus ga jarirai a asibiti don rigakafin gudawa da zubar rotavirus. Lancet 1994; 344: 1046-9. Duba m.
  167. Scarpignato C, Rampal P. Rigakafin da maganin zawo na matafiyi: Hanyar likitancin asibiti. Chemotherapy 1995; 41: 48-81. Duba m.
  168. Elmer GW, Surawicz CM, McFarland LV. Ma'aikatan Biotherapeutic, Hanyar da aka yi watsi da ita don magani da rigakafin zaɓin cututtukan hanji da na farji. JAMA 1996; 275: 870-5. Duba m.
Binciken na ƙarshe - 11/25/2020

Mafi Karatu

Cutar sankarau: Hotunan Rash da sauran cututtukan
Kiwon Lafiya

Cutar sankarau: Hotunan Rash da sauran cututtukan

Menene cutar ankarau?Cutar ankarau kumburi ne daga cikin a an jikin kwakwalwa da laka. Zai iya zama aboda kwayar cuta, fungal, ko kwayar cuta ta kwayan cuta. Babban abin da ya fi kamuwa da cutar anka...
Abubuwa 23 da Za a Sanin Game da Ciwon Muscle Mai Raɗaɗi da Farko
Kiwon Lafiya

Abubuwa 23 da Za a Sanin Game da Ciwon Muscle Mai Raɗaɗi da Farko

Idan ya zo ga ciwon t oka, akwai nau'i biyu:ciwon t oka mai t anani, wanda ake kira da ciwon t oka nan da nanjinkirta farawa ciwon t oka (DOM )Wannan galibi ana bayyana hi azaman zafi mai zafi. Ha...